Back

RxCe.com LLC

  • Deprescriptions
  • Dosage Forms
  • Drug Substitution
  • Palliative Care
  • Polypharmacy

Individualized Dosing and Treatment Plans for Adult Patients

Not all adult patients metabolize, tolerate, or respond to medications in the same ways, yet prescribing often relies on standardized doses, dosage forms, and schedules. Individualized dosing, including adjustments to the drug, dose, route, frequency, or formulation tailored to the patient, is an important component of patient-centered care and shared decision-making. With polypharmacy increasingly common in adults, particularly older adults, ensuring medication regimens align with patient-specific needs has become a routine part of clinical practice. This continuing education activity provides members of the healthcare team, including physicians, physician assistants, pharmacists, and pharmacy technicians, with a practical, interprofessional approach to developing individualized treatment plans for adult patients. Learners will review clinical and patient-specific factors that influence medication selection and dosing, including age, renal and hepatic function, pharmacogenomics, concurrent medications, adherence patterns, and patient goals of care. They will also examine approaches to dose titration, tapering, deprescribing, and review dosage-form modification, therapeutic substitution, and monitoring in adult patients with complex medication needs. Finally, this activity addresses shared decision-making, interprofessional communication and collaboration, and documentation strategies that support safe implementation and follow-up of individualized treatment plans.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditPharmacyUp to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 pointABIM — Practice AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No
Start Date
June 13, 2026
End Date
June 14, 2027

Pricing

Paid

This provider typically $6.99

See fees on rxce.com

Listed by the provider

  • Live
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Paid · this provider typically $6.99
  • When
    Jun 13, 2026 – Jun 13, 2027